+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rectal administration of artemisinin derivatives for the treatment of malaria



Rectal administration of artemisinin derivatives for the treatment of malaria



JAMA 297(21): 2381-2390



Rectal administration of artemisinin derivatives is a potentially lifesaving emergency treatment of severe malaria. Many different preparations are marketed in tropical countries, but their pharmacokinetic disposition and clinical efficacy may vary. To review the pharmacokinetics, efficacy, and safety of rectally administered artesunate, artemisinin, dihydroartemisinin, and artemether. We searched the MEDLINE, EMBASE, Cochrane Database of Clinical Reviews, Global Health, Web of Science, and CINAHL computerized databases up to December 2006, along with reviewing unpublished data from conference proceedings, pharmaceutical companies, and regulatory applications. Studies in languages other than English were translated. Studies were included involving rectal administration of an artemisinin derivative to healthy volunteers or patients with measurement of plasma drug concentrations or rates of initial parasite clearance. Both single-arm and comparative trials were included. Forty-five studies were identified, of which 39 eligible studies were included in the review. Primary efficacy outcome measures included parasite density as a percentage of baseline at 12 and 24 hours following the first dose. Pharmacokinetic variables included maximum plasma concentration (C(max)), time to C(max) (T(max)), and area under the plasma concentration-time curve. Weighted means were calculated from available data. Thirty-two studies provided valid clinical efficacy data: 19 of artesunate, 10 of artemisinin, 2 of dihydroartemisinin, and 1 of artemether. All demonstrated prompt parasite clearance, with evidence of a dose-dependent effect for artesunate. Mortality rates in severe malaria (weighted means, 0%-13%) were consistent with those expected. Eight studies compared rectal artemisinin with conventional parenteral treatment (quinine, artemether, or artesunate) for severe malaria. Despite similar clinical outcomes, rectal artemisinin derivatives initiated parasite clearance more rapidly than parenteral treatment (percentage of baseline at 12 hours, < or =27% vs > or =56%, respectively). Eighteen pharmacokinetic studies were identified, including 13 of artesunate. There was marked interindividual variability in most pharmacokinetic variables, but artesunate achieved an earlier T(max) and higher C(max) and area under the plasma concentration-time curve than other artemisinin derivatives. Available rectal preparations of artemisinin derivatives differ in their pharmacokinetic disposition. Most available evidence pertains to artesunate and artemisinin. Despite marked interindividual variability in bioavailability, rectal preparations appear to have acceptable therapeutic efficacy, including in severe illness.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 014163580

Download citation: RISBibTeXText

PMID: 17551131

DOI: 10.1001/jama.297.21.2381


Related references

Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children. Clinical Pharmacokinetics 52(3): 153-167, 2013

Malaria-infected mice are cured by oral administration of new artemisinin derivatives. Journal of Medicinal Chemistry 51(4): 1035-1042, 2008

Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clinical Pharmacology and Therapeutics 63(4): 482-493, 1998

Comparison of rectal artemisinin with intravenous quinine in the treatment of severe malaria in Ethiopia. East African Medical Journal 76(3): 154-159, 1999

Use of artemisinin and its derivatives for the treatment of malaria in children. Pediatric Infectious Disease Journal 33(5): 522-524, 2014

Artemisinin and derivatives: the future for malaria treatment?. Current Opinion in Infectious Diseases 14(6): 719-726, 2002

Use of Artemisinin (Qinghaosu) derivatives in the treatment of malaria. African Journal of Health Sciences 5(1): 8-11, 2007

Artemisinin and derivatives in the treatment of uncomplicated malaria. Medecine Tropicale 58(3 Suppl): 54-56, 1999

Artemisinin and derivatives: the future for malaria treatment?. Current Opinion in Infectious Diseases 14(6): 719-726, 2001

Review of the use of artemisinin and its derivatives in the treatment of malaria. Journal de Pharmacie de Belgique 60(1): 23-29, 2005

Artemisinin derivatives in the treatment of falciparum malaria in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene 92(4): 430-433, 1998

Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 Suppl 1: S5-S6, 1994

Safety evaluations of drugs containing artemisinin derivatives for the treatment of malaria. Clinical Infectious Diseases 36(12): 1626-7; Author Reply 1627-8, 2003

Treatment of children with malaria Plasmodium falciparum with derivatives artemisinin. Revista Da Sociedade Brasileira de Medicina Tropical 36(2): 223-226, 2003

Current status of the artemisinin derivatives in the treatment of malaria with focus on arteether. Journal of Parasitic Diseases 21(1): 1-12, 1997